Literature DB >> 18350258

The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.

Jitka Holcakova1, Pavla Ceskova, Roman Hrstka, Petr Muller, Lenka Dubska, Philip J Coates, Emil Palecek, Borivoj Vojtesek.   

Abstract

p73, a member of the p53 family, exhibits activities similar to those of p53, including the ability to induce growth arrest and apoptosis. p73 influences chemotherapeutic responses in human cancer patients, in association with p53. Alternative splicing of the TP73 gene produces many p73 C- and N-terminal isoforms, which vary in their transcriptional activity towards p53-responsive promoters. In this paper, we show that the C-terminal spliced isoforms of the p73 protein differ in their DNA-binding capacity, but this is not an accurate predictor of transcriptional activity. In different p53-null cell lines, p73beta induces either mitochondrial-associated or death receptor-mediated apoptosis, and these differences are reflected in different gene expression profiles. In addition, p73 induces cell cycle arrest and p21(WAF1) expression in H1299 cells, but not in Saos-2. This data shows that TAp73 isoforms act differently depending on the tumour cell background, and have important implications for p73-mediated therapeutic responses in individual human cancer patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350258      PMCID: PMC6275725          DOI: 10.2478/s11658-008-0011-z

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  27 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Transcriptional activities of p73 splicing variants are regulated by inter-variant association.

Authors:  Y Ueda; M Hijikata; S Takagi; T Chiba; K Shimotohno
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

3.  Rearrangement of the p53 gene in human osteogenic sarcomas.

Authors:  H Masuda; C Miller; H P Koeffler; H Battifora; M J Cline
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Mapping of the p53 and mdm-2 interaction domains.

Authors:  J Chen; V Marechal; A J Levine
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

5.  Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.

Authors:  Mauro Lanza; Barbara Marinari; Marina Papoutsaki; Maria Laura Giustizieri; Yuri D'Alessandra; Sergio Chimenti; Luisa Guerrini; Antonio Costanzo
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

6.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

7.  Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.

Authors:  Vaclav Brazda; Petr Muller; Kristyna Brozkova; Borivoj Vojtesek
Journal:  Biochem Biophys Res Commun       Date:  2006-10-19       Impact factor: 3.575

8.  An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

Authors:  B Vojtĕsek; J Bártek; C A Midgley; D P Lane
Journal:  J Immunol Methods       Date:  1992-07-06       Impact factor: 2.303

Review 9.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Expression of p53 isoforms in squamous cell carcinoma of the head and neck.

Authors:  Linda Boldrup; Jean-Christophe Bourdon; Philip J Coates; Björn Sjöström; Karin Nylander
Journal:  Eur J Cancer       Date:  2007-01-09       Impact factor: 9.162

View more
  7 in total

1.  Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma.

Authors:  Yuming Chen
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

2.  Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Authors:  Rosario Gil-Benso; Javier Megías; Teresa San-Miguel; Sandra Pinto; Robert C Callaghan; Concha López-Ginés; Miguel Cerdá-Nicolás
Journal:  Cytotechnology       Date:  2017-07-04       Impact factor: 2.058

3.  Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73 /ΔNp73.

Authors:  Cuixia Di; Chao Sun; Hongyan Li; Jing Si; Hong Zhang; Lu Han; Qiuyue Zhao; Yang Liu; Bin Liu; Guoying Miao; Lu Gan; Yuanyuan Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Role of Bax/Bcl-2 family members in green tea polyphenol induced necroptosis of p53-deficient Hep3B cells.

Authors:  Weiping Lin; Sun Tongyi
Journal:  Tumour Biol       Date:  2014-05-19

5.  P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.

Authors:  S Al-Bahlani; M Fraser; A Y C Wong; B S Sayan; R Bergeron; G Melino; B K Tsang
Journal:  Oncogene       Date:  2011-04-25       Impact factor: 9.867

6.  Adenovirus-mediated decorin expression induces cancer cell death through activation of p53 and mitochondrial apoptosis.

Authors:  A-Rum Yoon; JinWoo Hong; Chae-Ok Yun
Journal:  Oncotarget       Date:  2017-09-08

7.  Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.

Authors:  Ling Gao; Li Wang; Zhen Sun; Haiyan Li; Qiaoping Wang; Cheng Yi; Xiujie Wang
Journal:  Drug Des Devel Ther       Date:  2017-06-16       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.